Factors affecting longitudinal trajectories of plasma sphingomyelins: The Baltimore longitudinal study of aging

Aging Cell

Volumn 14, Issue 1, 2015, Pages 112-121

  Mielke, Michelle M ^a   Bandaru, Veera Venkata Ratnam ^b   Han, Dingfen ^b   An, Yang ^c   Resnick, Susan M ^c   Ferrucci, Luigi ^c   Haughey, Norman J ^b  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Dihydrosphingomyelin; Human; Longitudinal; Sex differences; Sphingomyelin

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; DIHYDROSPHINGOMYELIN; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; AGING; ARTICLE; ASSOCIATION; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENOTYPE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS; MARYLAND; MIDDLE AGED; STANDARD;

AGING; APOLIPOPROTEIN E4; BALTIMORE; CHOLESTEROL; DEMOGRAPHY; FEMALE; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REFERENCE STANDARDS; SPHINGOMYELINS; TRIGLYCERIDES;

EID: 84922611821     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12275     Document Type: Article

References (36)

1. Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68, 1481-1487.
2. Bandaru VV, Patel N, Ewaleifoh O, Haughey NJ (2011) A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. J. Neuroimmune Pharmacol. 6, 640-649.
3. Bandaru VV, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ (2013) A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology 81, 1492-1499.
4. Contreras FX, Ernst AM, Haberkant P, Bjorkholm P, Lindahl E, Gonen B, Tischer C, Elofsson A, von Heijne G, Thiele C, Pepperkok R, Wieland F, Brugger B (2012) Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 481, 525-529.
5. Deeley JM, Hankin JA, Friedrich MG, Murphy RC, Truscott RJ, Mitchell TW, Blanksby SJ (2010) Sphingolipid distribution changes with age in the human lens. J. Lipid Res. 51, 2753-2760.
6. Fernandez C, Sandin M, Sampaio JL, Almgren P, Narkiewicz K, Hoffmann M, Hedner T, Wahlstrand B, Simons K, Shevchenko A, James P, Melander O (2013) Plasma lipid composition and risk of developing cardiovascular disease. PLoS ONE 8, e71846.
7. Gatt S, Bierman EL (1980) Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. J. Biol. Chem. 255, 3371-3376.
8. Gonzalez-Covarrubias V, Beekman M, Uh HW, Dane A, Troost J, Paliukhovich I, van der Kloet FM, Houwing-Duistermaat J, Vreeken RJ, Hankemeier T, Slagboom EP (2013) Lipidomics of familial longevity. Aging Cell 12, 426-434.
9. Hammad SM, Pierce JS, Soodavar F, Smith KJ, Al Gadban MM, Rembiesa B, Klein RL, Hannun YA, Bielawski J, Bielawska A (2010) Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J. Lipid Res. 51, 3074-3087.
10. Hannun YA, Obeid LM (2011) Many ceramides. J. Biol. Chem. 286, 27855-27862.
11. Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann. Neurol. 55, 257-267.
12. Haughey NJ, Bandaru VV, Bae M, Mattson MP (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim. Biophys. Acta 1801, 878-886.
13. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548.
14. Holzer M, Trieb M, Konya V, Wadsack C, Heinemann A, Marsche G (2013) Aging affects high-density lipoprotein composition and function. Biochim. Biophys. Acta 1831, 1442-1448.
15. Jiang XC, Paultre F, Pearson TA, Reed RG, Francis CK, Lin M, Berglund L, Tall AR (2000) Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20, 2614-2618.
16. Kim IC, Lee JH, Bang G, Choi SH, Kim YH, Kim KP, Kim HK, Ro J (2013) Lipid profiles for HER2-positive breast cancer. Anticancer Res. 33, 2467-2472.
17. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Muller J, Schomig A, Kastrati A (2002) TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin. Chem. Lab. Med. 40, 1123-1131.
18. Kuikka M, Ramstedt B, Ohvo-Rekila H, Tuuf J, Slotte JP (2001) Membrane properties of D-erythro-N-acyl sphingomyelins and their corresponding dihydro species. Biophys. J. 80, 2327-2337.
19. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG (2011) Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J. Alzheimers Dis. 27, 259-269.
20. Milhas D, Clarke CJ, Hannun YA (2010) Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids. FEBS Lett. 584, 1887-1894.
21. Montefusco DJ, Chen L, Matmati N, Lu S, Newcomb B, Cooper GF, Hannun YA, Lu X (2013) Distinct signaling roles of ceramide species in yeast revealed through systematic perturbation and systems biology analyses. Sci. Signal 6, rs14.
22. Nelson JC, Jiang XC, Tabas I, Tall A, Shea S (2006) Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 163, 903-912.
23. Petersen NH, Olsen OD, Groth-Pedersen L, Ellegaard AM, Bilgin M, Redmer S, Ostenfeld MS, Ulanet D, Dovmark TH, Lonborg A, Vindelov SD, Hanahan D, Arenz C, Ejsing CS, Kirkegaard T, Rohde M, Nylandsted J, Jaattela M (2013) Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase. Cancer Cell 24, 379-393.
24. Quinn PJ, Wolf C (2009) The liquid-ordered phase in membranes. Biochim. Biophys. Acta 1788, 33-46.
25. Schlitt A, Blankenberg S, Yan D, von Gizycki H, Buerke M, Werdan K, Bickel C, Lackner KJ, Meyer J, Rupprecht HJ, Jiang XC (2006) Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr. Metab. 3, 5.
26. Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R (1989) Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J. Gerontol. 44, M66-M73.
27. Shock NW, Greulich RC, Andres R, Arenberg D, Costa PT Jr, Lakatta EG, Tobin JD (1984) Normal Human Aging: The Baltimore Longitudinal Study of Aging. Washington, DC: U.S. Government Printing Office.
28. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387, 569-572.
29. Simons K, Vaz WL (2004) Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33, 269-295.
30. Slotte JP, Bierman EL (1988) Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250, 653-658.
31. Vaarhorst AA, Beekman M, Suchiman EH, van Heemst D, Houwing-Duistermaat JJ, Westendorp RG, Slagboom PE, Heijmans BT (2011) Lipid metabolism in long-lived families: the Leiden Longevity Study. Age (Dordr) 33, 219-227.
32. Vieira CR, Munoz-Olaya JM, Sot J, Jimenez-Baranda S, Izquierdo-Useros N, Abad JL, Apellaniz B, Delgado R, Martinez-Picado J, Alonso A, Casas J, Nieva JL, Fabrias G, Manes S, Goni FM (2010) Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains. Chem. Biol. 17, 766-775.
33. Vouk K, Hevir N, Ribic-Pucelj M, Haarpaintner G, Scherb H, Osredkar J, Moller G, Prehn C, Rizner TL, Adamski J (2012) Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum. Reprod. 27, 2955-2965.
34. Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, Comuzzie AG, Mahaney MC, Jowett JB, Shaw J, Curran JE, Blangero J, Meikle PJ (2013) Plasma lipid profiling in a large population-based cohort. J. Lipid Res. 54, 2898-2908.
35. Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, Shea S (2010) Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 628-633.
36. Yu Z, Zhai G, Singmann P, He Y, Xu T, Prehn C, Romisch-Margl W, Lattka E, Gieger C, Soranzo N, Heinrich J, Standl M, Thiering E, Mittelstrass K, Wichmann HE, Peters A, Suhre K, Li Y, Adamski J, Spector TD, Illig T, Wang-Sattler R (2012) Human serum metabolic profiles are age dependent. Aging Cell 11, 960-967.